Search clinical trials for: T315I
Total 17 results
-
Terns, Inc.Not yet recruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic PhaseUnited States
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia
-
Ascentage Pharma Group Inc.RecruitingMyeloid Leukemia | Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Leukemia, Myeloid, Chronic | B Cell Precursor Type Acute LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid Leukemia With T315I MutationSwitzerland
-
Otsuka Beijing Research InstituteActive, not recruitingAcute Lymphoblastic Leukemia | Chronic Myeloid LeukemiaChina
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia, Chronic PhaseChina
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia - Accelerated PhaseChina
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaFrance
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
University of UtahBoston University; University of Pennsylvania; Northwestern University; Columbia... and other collaboratorsCompleted
-
Ariad PharmaceuticalsCompletedChronic Myeloid Leukemia | Ph+ Acute Lymphoblastic LeukemiaFrance, Belgium, Australia, Singapore, Germany, Spain, United Kingdom, Netherlands, Italy, Korea, Republic of, Sweden
-
Fusion Pharma LLCData Matrix Solutions; OCT Rus, LLC; Skolkovo Innovation CenterUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myeloid LeukemiaRussian Federation
-
Hospices Civils de LyonCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Deciphera Pharmaceuticals LLCCompletedChronic Myeloid LeukemiaUnited States